Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Application of Circulating Tumor DNA (ctDNA) to Guided the Late-Line Treatment for Patients With Late-Stage Breast Cancer

NCT05427617 is registered in ClinicalTrials.gov with Hunan Cancer Hospital as lead sponsor.

NCT NCT05427617
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05427617 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Application of Circulating Tumor DNA (ctDNA) to Guided the Late-Line Treatment for Patients With Late-Stage Breast Cancer
Lead sponsor
Hunan Cancer Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2016
Completion date
June 30, 2021
Enrollment
223 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor dna, gene abnormality, metastatic breast cancer